Target intelligence / Profile preview

Phospholipase A2 group XI, pseudogene (PLA2G10IP)

Target: PLA2G10IP
Molecular classification: Other (Pseudogene)

Overview

PLA2G10IP designates a pseudogene with sequence homology to the functional phospholipase A2 group XI enzymes, but it does not produce an active or functional protein product. Pseudogenes are typically non-functional remnants of genes and do not serve as drug targets, biomarkers, or have established biological roles. There are no known disease associations, physiological functions, or interacting drugs because the gene product is non-functional[1][4]. Because PLA2G10IP is a pseudogene, it should not be considered a therapeutic target or an active biomolecule. This entry is likely not relevant for drug discovery or biological targeting.

Other names: PLA2G10IPphospholipase A2 group XI, pseudogene

Beyond the preview

Go deeper on Phospholipase A2 group XI, pseudogene (PLA2G10IP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholipase A2 group XI, pseudogene (PLA2G10IP).

Explore the full profile